BiotechTube

helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + Placebo + helicobacter pylori vaccine + helicobacter pylori vaccine

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Helicobacter Pylori

Conditions

Helicobacter Pylori, Gastritis, Gastric Cancer, Gastroduodenal Ulcers, Lymphoma

Trial Timeline

Feb 1, 2001 → Apr 1, 2002

NCT ID
NCT00613665

About helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + Placebo + helicobacter pylori vaccine + helicobacter pylori vaccine

helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + helicobacter pylori vaccine + Placebo + helicobacter pylori vaccine + helicobacter pylori vaccine is a phase 1 stage product being developed by Novartis for Helicobacter Pylori. The current trial status is completed. This product is registered under clinical trial identifier NCT00613665. Target conditions include Helicobacter Pylori, Gastritis, Gastric Cancer.

What happened to similar drugs?

2 of 4 similar drugs in Helicobacter Pylori were approved

Approved (2) Terminated (0) Active (2)
✅Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapySun PharmaceuticalApproved
✅pantoprazole + bismuth + metronidazole + tetracyclinePacific BiosciencesApproved
🔄Vonoprazan + Amoxicillin + Clarithromycin + LansoprazolePhathom PharmaceuticalsPhase 3
🔄RHB-105 + Active ComparatorRedHill BiopharmaPhase 3

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00613665Phase 1Completed

Competing Products

6 competing products in Helicobacter Pylori

See all competitors
ProductCompanyStageHype Score
Ilaprazole antisecretory drug of each quadruple therapy the Ilaprazole -based quadruple therapy + Esoprazole antisecretory drug of each quadruple therapy Esoprazole-based quadruple therapySun PharmaceuticalApproved
43
Rabeprazole SodiumEisaiPre-clinical
26
H.pylori vaccines + Placebo VaccineNovartisPhase 1
29
Vonoprazan + Amoxicillin + Clarithromycin + LansoprazolePhathom PharmaceuticalsPhase 3
34
pantoprazole + bismuth + metronidazole + tetracyclinePacific BiosciencesApproved
33
RHB-105 + Active ComparatorRedHill BiopharmaPhase 3
30